摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-methyl-9,10-didehydro-ergoline-8-carboxylic acid ethylamide | 478-99-9

中文名称
——
中文别名
——
英文名称
6-methyl-9,10-didehydro-ergoline-8-carboxylic acid ethylamide
英文别名
D-Lysergic acid monoethylamide;N-ethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
6-methyl-9,10-didehydro-ergoline-8-carboxylic acid ethylamide化学式
CAS
478-99-9;53543-74-1
化学式
C18H21N3O
mdl
——
分子量
295.384
InChiKey
VEBWTGYUIBTVNR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    153-155 °C(Solv: ethyl acetate (141-78-6))
  • 沸点:
    437.06°C (rough estimate)
  • 密度:
    1.1190 (rough estimate)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    48.1
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:9f9d15962d540bbe950c8f7b5652d3ac
查看

文献信息

  • [EN] 5HT7 RECEPTOR LIGANDS AND COMPOSITIONS COMPRISING THE SAME<br/>[FR] LIGANDS DU RÉCEPTEUR 5-HT7 ET COMPOSITIONS LES CONTENANT
    申请人:ESTEVE LABOR DR
    公开号:WO2010012817A2
    公开(公告)日:2010-02-04
    The present invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, especially as agonists, identified by using a pharmacophore and a descriptor's profile filter as well as to pharmaceutical compositions comprising them. These compounds are useful in therapy in particular for the treatment and or prophylaxis of a disease in which 5-HT7 is involved, such as CNS disorders.
  • [EN] METHOD FOR SCREENING OF 5HT7 RECEPTOR LIGANDS BASED ON A NEW PHARMACOPHORE MODEL AND A DESCRIPTOR'S PROFILE FILTER<br/>[FR] PROCÉDÉ DE CRIBLAGE DE LIGANDS DU RÉCEPTEUR 5HT7, SUR LA BASE D'UN NOUVEAU MODÈLE PHARMACOPHORE ET D'UN FILTRE DE PROFIL DE DESCRIPTEUR
    申请人:ESTEVE LABOR DR
    公开号:WO2010012811A2
    公开(公告)日:2010-02-04
    The present invention relates to compounds having pharmacological activity towards the 5-HT7 receptor; to a method for identifying them as 5-HT7 ligands, especially as agonists, by using a pharmacophore and a descriptor's profile filter; to pharmaceutical compositions comprising them; and to their use in therapy, in particular for the treatment and or prophylaxis of a disease in which 5-HT7 is involved, such as CNS disorders.
查看更多